Department of Urology, Liv Hospital Samsun, Samsun, Turkey.
Department of Urology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
J Endourol. 2021 May;35(5):615-622. doi: 10.1089/end.2020.0758. Epub 2020 Nov 5.
Partial nephrectomy (PN) is the standard of treatment in patients with cT1 renal tumors. Current guidelines recommend PN as a standard of treatment in patients with cT1 renal tumors. However, the commonly accepted criteria for which surgical outcomes are evaluated both functionally and oncologically are not yet clear. The aim of this study was to evaluate compounding factors that affect the operative and functional outcomes for laparoscopic partial nephrectomy (LPN) in patients with cT1 renal tumors. This study was registered at NCT04213157 for patients who underwent LPN with the diagnosis of clinical T1 renal tumors. Between November 2009 and August 2018, 292 patients were included in the study. The patients were allocated into two groups according to the tumor size: T1a ( = 215) and T1b ( = 77). Demographic features, clinical tumor characteristics, and intraoperative and postoperative outcomes were analyzed. A negative surgical margin, warm ischemia time of <20 minutes, and no postoperative major complications were accepted to achieve the trifecta outcomes. Pentafecta was defined as trifecta criteria plus >90% preservation of baseline renal function (RF) and no stage upgrade of chronic kidney disease at 12 months after surgery. Univariate and multivariate analyses were used to identify factors predicting trifecta and pentafecta. Preoperative variables including age, gender, and baseline RF were similar between the two groups. The warm ischemia time was 13.4 15.9 minutes ( = 0.001). The positive margin rate was 0.9% 2.6% ( = 0.284), and the major complication rate was 3.3% 2.6% ( = 0.548). The achievement of the trifecta rate was 88.4% 75.3% ( = 0.006) and pentafecta rate was 72.6% 42.9% ( = 0.001). Multivariate analysis showed that tumor complexity, baseline RF, and diabetes mellitus are independent predictors of achieving pentafecta outcomes. LPN is an effective and reliable method for renal tumors even in T1b with satisfying surgical and functional outcomes.
部分肾切除术(PN)是 cT1 肾肿瘤患者的标准治疗方法。目前的指南建议将 PN 作为 cT1 肾肿瘤患者的标准治疗方法。然而,目前尚不清楚哪些手术结果在功能和肿瘤学上都得到普遍认可的标准。本研究旨在评估影响 cT1 肾肿瘤患者腹腔镜部分肾切除术(LPN)手术和功能结果的复合因素。本研究在 NCT04213157 注册,纳入了接受诊断为临床 T1 肾肿瘤的 LPN 患者。在 2009 年 11 月至 2018 年 8 月期间,共有 292 名患者入组。根据肿瘤大小将患者分为两组:T1a( = 215)和 T1b( = 77)。分析了患者的人口统计学特征、临床肿瘤特征、术中及术后结果。阴性切缘、热缺血时间<20 分钟和无术后重大并发症被认为是实现三联征的结果。五重奏定义为三联征标准加上基线肾功能(RF)保留>90%和术后 12 个月慢性肾脏病分期无升级。使用单变量和多变量分析来确定预测三联征和五重奏的因素。两组患者的术前变量(年龄、性别和基线 RF)相似。热缺血时间为 13.4 15.9 分钟( = 0.001)。阳性切缘率为 0.9% 2.6%( = 0.284),主要并发症发生率为 3.3% 2.6%( = 0.548)。三联征的实现率为 88.4% 75.3%( = 0.006),五重奏的实现率为 72.6% 42.9%( = 0.001)。多变量分析显示,肿瘤复杂性、基线 RF 和糖尿病是实现五重奏结果的独立预测因素。LPN 是一种有效的、可靠的治疗肾肿瘤的方法,即使在 T1b 肿瘤中,也能获得令人满意的手术和功能结果。